Dr. Chennamadhavuni is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Coffee Rd
Modesto, CA 95355Phone+1 209-550-4795
Education & Training
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2019 - 2020
- Gundersen Lutheran Medical FoundationResidency, Internal Medicine, 2017
- Gundersen Lutheran Medical FoundationResidency, Internal Medicine, 2013 - 2016
- Osmania Medical College NTR UHSClass of 2011
Certifications & Licensure
- CA State Medical License 2021 - 2025
- IA State Medical License 2017 - 2022
- WI State Medical License 2016 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 21 citationsSurvival trends among patients with metastatic melanoma in the pretargeted and the post-targeted era: a US population-based study.Dipesh Uprety, Amir Bista, Adithya Chennamadhavuni, Abesh Niroula, Syed Imran Mustafa Jafri
Melanoma Research. 2018-02-01 - 119 citationsTherapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors.Praveen Vikas, Nicholas Borcherding, Adithya Chennamadhavuni, Rohan Garje
Frontiers in Oncology. 2020-04-28 - 12 citationsMultivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based Immunotherapies.Umang Swami, Adithya Chennamadhavuni, Nicholas Borcherding, Aaron D. Bossler, Sarah L. Mott
Antibiotics. 2020-10-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: